BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29673714)

  • 1. Discovery and evaluation of nNa
    Dutta S; Lopez Charcas O; Tanner S; Gradek F; Driffort V; Roger S; Selander K; Velu SE; Brouillette W
    Bioorg Med Chem; 2018 May; 26(9):2428-2436. PubMed ID: 29673714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neonatal splice variant of Nav1.5 potentiates in vitro invasive behaviour of MDA-MB-231 human breast cancer cells.
    Brackenbury WJ; Chioni AM; Diss JK; Djamgoz MB
    Breast Cancer Res Treat; 2007 Jan; 101(2):149-60. PubMed ID: 16838113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential for phenytoin: targeting Na(v)1.5 sodium channels to reduce migration and invasion in metastatic breast cancer.
    Yang M; Kozminski DJ; Wold LA; Modak R; Calhoun JD; Isom LL; Brackenbury WJ
    Breast Cancer Res Treat; 2012 Jul; 134(2):603-15. PubMed ID: 22678159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer invasiveness in vitro: Predominant contribution of neonatal Nav1.5 under normoxia and hypoxia.
    Guzel RM; Ogmen K; Ilieva KM; Fraser SP; Djamgoz MBA
    J Cell Physiol; 2019 May; 234(5):6582-6593. PubMed ID: 30341901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sigma-1 receptors modulate neonatal Na
    Aydar E; Stratton D; Fraser SP; Djamgoz MB; Palmer C
    Eur Biophys J; 2016 Oct; 45(7):671-683. PubMed ID: 27160185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal Nav1.5 protein expression in normal adult human tissues and breast cancer.
    Yamaci RF; Fraser SP; Battaloglu E; Kaya H; Erguler K; Foster CS; Djamgoz MBA
    Pathol Res Pract; 2017 Aug; 213(8):900-907. PubMed ID: 28698102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent Inactivation-Dependent Inhibition of Adult and Neonatal NaV1.5 Channels by Lidocaine and Levobupivacaine.
    Elajnaf T; Baptista-Hon DT; Hales TG
    Anesth Analg; 2018 Sep; 127(3):650-660. PubMed ID: 29958221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effects of phenytoin and DAPT on MDA-MB-231 breast cancer cells.
    Aktas CC; Zeybek ND; Piskin AK
    Acta Biochim Biophys Sin (Shanghai); 2015 Sep; 47(9):680-6. PubMed ID: 26206582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pharmacology of voltage-gated sodium channel expression in metastatic disease: clinical potential of neonatal Nav1.5 in breast cancer.
    Onkal R; Djamgoz MB
    Eur J Pharmacol; 2009 Dec; 625(1-3):206-19. PubMed ID: 19835862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeic acid phenethyl ester: Inhibition of metastatic cell behaviours via voltage-gated sodium channel in human breast cancer in vitro.
    Fraser SP; Hemsley F; Djamgoz MBA
    Int J Biochem Cell Biol; 2016 Feb; 71():111-118. PubMed ID: 26724521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the TRPM8 inhibitor AMTB in breast cancer cells and its identification as an inhibitor of voltage gated sodium channels.
    Yapa KTDS; Deuis J; Peters AA; Kenny PA; Roberts-Thomson SJ; Vetter I; Monteith GR
    Life Sci; 2018 Apr; 198():128-135. PubMed ID: 29496495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase A and regulation of neonatal Nav1.5 expression in human breast cancer cells: activity-dependent positive feedback and cellular migration.
    Chioni AM; Shao D; Grose R; Djamgoz MB
    Int J Biochem Cell Biol; 2010 Feb; 42(2):346-58. PubMed ID: 19948241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro effects of the FS50 protein from salivary glands of Xenopsylla cheopis on voltage-gated sodium channel activity and motility of MDA-MB-231 human breast cancer cells.
    Zhang B; Deng Z; Zeng B; Yang S; Chen X; Xu X; Wu J
    Anticancer Drugs; 2018 Oct; 29(9):880-889. PubMed ID: 29912729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naringenin inhibits prostate cancer metastasis by blocking voltage-gated sodium channels.
    Gumushan Aktas H; Akgun T
    Biomed Pharmacother; 2018 Oct; 106():770-775. PubMed ID: 29990870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of voltage-gated sodium channel alpha subunit in human ovarian cancer.
    Gao R; Shen Y; Cai J; Lei M; Wang Z
    Oncol Rep; 2010 May; 23(5):1293-9. PubMed ID: 20372843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of neonatal Nav1.5 in human brain astrocytoma and its effect on proliferation, invasion and apoptosis of astrocytoma cells.
    Xing D; Wang J; Ou S; Wang Y; Qiu B; Ding D; Guo F; Gao Q
    Oncol Rep; 2014 Jun; 31(6):2692-700. PubMed ID: 24756536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nav1.5 regulates breast tumor growth and metastatic dissemination in vivo.
    Nelson M; Yang M; Millican-Slater R; Brackenbury WJ
    Oncotarget; 2015 Oct; 6(32):32914-29. PubMed ID: 26452220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of voltage-gated sodium channels inhibits invasion of endocrine-resistant breast cancer cells.
    Mohammed FH; Khajah MA; Yang M; Brackenbury WJ; Luqmani YA
    Int J Oncol; 2016 Jan; 48(1):73-83. PubMed ID: 26718772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of NaV 1.6 channels is associated with the invasion capacity of human cervical cancer.
    Hernandez-Plata E; Ortiz CS; Marquina-Castillo B; Medina-Martinez I; Alfaro A; Berumen J; Rivera M; Gomora JC
    Int J Cancer; 2012 May; 130(9):2013-23. PubMed ID: 21630263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetrodotoxin-sensitive α-subunits of voltage-gated sodium channels are relevant for inhibition of cardiac sodium currents by local anesthetics.
    Stoetzer C; Doll T; Stueber T; Herzog C; Echtermeyer F; Greulich F; Rudat C; Kispert A; Wegner F; Leffler A
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):625-36. PubMed ID: 27000037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.